Drug Development

Drug development can also benefit from bioprinting

Anti-cancer drug development is inefficient, the high fail rate is partly due to the lack of predictive models or the inadequate use of existing preclinical test systems. Using bioprinting we can create 3D structures containing tumoral cells and tissues that can better simulate the native 3D tumor microenvironment that favours tumor growth and progression.